๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

PS3-77 DCIR: A new therapeutic target for autoimmune disorders

โœ Scribed by Guangyu Ma; Noriyuki Fujikado; Tomonori Kaifu; Rikio Yabe; Takumi Maruhashi; Akimasa Seno; Yoichiro Iwakura

Book ID
116399884
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
50 KB
Volume
52
Category
Article
ISSN
1043-4666

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

GSK-3 is a viable potential target for t
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
โœ Michael K. Rowe; Charlotte Wiest; De-Maw Chuang ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 248 KB

Bipolar disorder is a serious psychiatric condition that has been treated for over 50 years with lithium. Lithium is a well established glycogen synthase kinase-3 (GSK-3) inhibitor, suggesting that manipulating GSK-3 may have therapeutic value in treating bipolar disorder. GSK-3 is regulated by a wi